glucagon

FDA Drug Profile — Baqsimi, Glucagon

Drug Details

Generic Name
glucagon
Brand Names
Baqsimi, Glucagon
Application Number
NDA210134
Sponsor
Amphastar Pharmaceuticals, Inc.
NDC Codes
5
Dosage Forms
POWDER, KIT
Routes
NASAL
Active Ingredients
GLUCAGON

Indications and Usage

1 INDICATIONS AND USAGE GVOKE is an antihypoglycemic agent indicated for subcutaneous use for the treatment of severe hypoglycemia in adult and pediatric patients aged two years and older with diabetes ( 1.1 ) GVOKE VialDx is a gastrointestinal motility inhibitor indicated for intravenous use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients ( 1.2 ) 1.1 Severe Hypoglycemia in Adult and Pediatric Patients Aged 2 Years and Older with Diabetes GVOKE is indicated for subcutaneous use for the treatment of severe hypoglycemia in adult and pediatric patients aged two and older with diabetes. 1.2 Diagnostic Aid in Adults GVOKE VialDx is indicated for intravenous use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients.